Report Clear cell renal cell carcinoma with BAP1 mutation: a report of two cases

被引:0
|
作者
Lee, Jennifer [1 ,2 ]
Thuzar, Moe [1 ,2 ]
DiPoto-Brahmbhatt, Angela C. [1 ,2 ]
Chaudoir, Catherine [1 ,2 ]
Tanner, Anthony [1 ]
Fazili, Tajammul [3 ,4 ]
Yu, Xiuping [4 ,5 ]
Constantinescu, Michael [1 ,2 ]
Yeh, Y. Albert [1 ,2 ,4 ]
机构
[1] Overton Brooks VA Med Ctr, Pathol & Lab Med Serv, 510 East Stoner Ave, Shreveport, LA 71101 USA
[2] Louisiana State Univ Hlth Shreveport, Dept Pathol & Translat Pathobiol, Shreveport, LA USA
[3] Overton Brooks VA Med Ctr, Dept Urol, Shreveport, LA USA
[4] Louisiana State Univ Hlth Shreveport, Dept Urol, Shreveport, LA USA
[5] Louisiana State Univ Hlth Shreveport, Dept Biochem & Mol Biol, Shreveport, LA USA
关键词
Clear cell renal cell carcinoma; BAP1; mutation; eosinophilic granules; hyaline globules; TUMOR-SUPPRESSOR; DIAGNOSIS;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Clear cell renal cell carcinoma is the most common subtype of renal cell carcinomas (RCCs) and accounts for 60%-70% of all RCCs cases in adults. Aberrations in the von Hippel-Lindau (VHL) gene on chromosome 3p occurred in > 90% of clear cell RCCs. Other tumor suppressor genes located on chromosome 3p, such as BAP1, PBRM1, and SETD2, also contribute to tumorigenesis. Clear cell RCCs with both BAP1 and VHL mutations may display distinctive histopathological features. Here, we report two cases of clear cell RCCs with BAP1 mutation. One tumor had VHL, BAP-1, and RAF1 mutations and the tumor nests and alveoli of tumor cells were surrounded by proliferative vessels and the optically clear cytoplasm contained numerous eosinophilic granules and hyaline globules of varying sizes. The other tumor had BAP1 and ATM mutations, and demonstrated clear cells with numerous eosinophilic granules and other typical histopathological features of conventional clear cell RCC. Furthermore, many tumor nodules with dense peripheral lymphocytic infiltrates contained rhabdoid cells. Sarcomatoid cells were also observed. Both tumor cells showed high-grade nuclei. Clear cell RCCs with BAP1 mutation exhibit aggressive clinical behaviors.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 50 条
  • [1] Expression of Bap1 in Clear Cell Renal Cell Carcinoma
    Fatima, Arooj
    JOURNAL OF PATHOLOGY, 2024, 264 : S12 - S12
  • [2] Advancements in Radiogenomics for Clear Cell Renal Cell Carcinoma: Understanding the Impact of BAP1 Mutation
    Greco, Federico
    D'Andrea, Valerio
    Buoso, Andrea
    Cea, Laura
    Bernetti, Caterina
    Zobel, Bruno Beomonte
    Mallio, Carlo Augusto
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [3] The expanding role of BAP1 in clear cell renal cell carcinoma
    Kapur, Payal
    Rajaram, Satwik
    Brugarolas, James
    HUMAN PATHOLOGY, 2023, 133 : 22 - 31
  • [4] A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
    Farley, Megan N.
    Schmidt, Laura S.
    Mester, Jessica L.
    Pena-Llopis, Samuel
    Pavia-Jimenez, Andrea
    Christie, Alana
    Vocke, Cathy D.
    Ricketts, Christopher J.
    Peterson, James
    Middelton, Lindsay
    Kinch, Lisa
    Grishin, Nick
    Merino, Maria J.
    Metwalli, Adam R.
    Xing, Chao
    Xie, Xian-Jin
    Dahia, Patricia L. M.
    Eng, Charis
    Linehan, W. Marston
    Brugarolas, James
    MOLECULAR CANCER RESEARCH, 2013, 11 (09) : 1061 - 1071
  • [5] BAP1 LOSS IS ASSOCIATED WITH METASTASIS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA
    Khaleel, Sari
    Reiner, Anne
    Brennan, Cameron
    Hussain, Ibrahim
    Berman, Samuel
    Hakimi, Ari
    Moss, Nelson
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1018 - E1018
  • [6] The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma
    Tan, Guobin
    Xuan, Zijun
    Li, Zhiqin
    Huang, Shuitong
    Chen, Guangming
    Wu, Yonglu
    Chen, Xianxi
    Liang, Zhijin
    Wu, Aiming
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1725 - 1734
  • [7] Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
    Jin, Shengming
    Wu, Junlong
    Zhu, Yao
    Gu, Weijie
    Wan, Fangning
    Xiao, Wenjun
    Dai, Bo
    Zhang, Hailiang
    Shi, Guohai
    Shen, Yijun
    Zhu, Yiping
    Ye, Dingwei
    JOURNAL OF CANCER, 2018, 9 (22): : 4108 - 4116
  • [8] A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
    Ge, Yu-Zheng
    Xu, Lu-Wei
    Zhou, Chang-Cheng
    Lu, Tian-Ze
    Yao, Wen-Tao
    Wu, Ran
    Zhao, You-Cai
    Xu, Xiao
    Hu, Zhi-Kai
    Wang, Min
    Yang, Xiao-Bing
    Zhou, Liu-Hua
    Zhong, Bing
    Xu, Zheng
    Li, Wen-Cheng
    Zhu, Jia-Geng
    Jia, Rui-Peng
    JOURNAL OF CANCER, 2017, 8 (13): : 2643 - 2652
  • [9] BAP1 Loss Defines a Pathologically Aggressive Subgroup of Clear Cell Renal Cell Carcinoma
    Kapur, P.
    Christie, A.
    Pena-Llopis, S.
    Margulis, V.
    Lotan, Y.
    Xie, X-J
    Brugarolas, J.
    LABORATORY INVESTIGATION, 2013, 93 : 223A - 223A
  • [10] The immune characteristic analysis of BAP1 mutated clear cell renal cell carcinoma.
    Wang, Zilin
    Liang, Jiayu
    Zeng, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 466 - 466